Marker gets $1.6M NIH grant to further screening technology

03/15/2012 | GenomeWeb Daily News (free registration)

The NIH's National Institute of Neurological Disorders and Stroke awarded Marker Gene Technologies a Phase II small business innovation research grant to help advance its screening technology for lysosomal storage disease drugs. Marker will use the three-year grant worth $1.6 million to develop live cell and tissue tests for drug candidates.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA